Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Mayo Clinic
OHSU Knight Cancer Institute
City of Hope Medical Center
Emory University
Mayo Clinic
Children's Oncology Group
NRG Oncology
National Cancer Institute (NCI)
Albert Einstein College of Medicine
Stanford University
Children's Oncology Group
Mayo Clinic
University of Florida
University of Iowa
Memorial Sloan Kettering Cancer Center
University of Washington
University of California, San Francisco
University of Pittsburgh
National Cancer Institute (NCI)
National Cancer Institute (NCI)
London Health Sciences Centre
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center